HACRO reaffirmed its commitment to advancing innovation in clinical research and supporting a patient-centred healthcare system through its participation in the 2nd Synergies Forum on Cancer Policy, Research & Funding Strategies, organised by the Hellenic Cancer Federation (ELLOK).
HACRO President Evangelia (Lia) Koraki participated in the panel discussion “Addressing Challenges in Clinical Trials,” where experts examined the current landscape of clinical trials in Greece and across Europe, explored future growth opportunities and discussed the key challenges faced by researchers, healthcare professionals and patients.
A central theme of the discussion was the importance of close collaboration among all stakeholders. Building a clinical research environment founded on trust, transparency and meaningful patient engagement is essential to strengthening Greece’s clinical research ecosystem and expanding access to innovative therapies.
HACRO extends its sincere thanks to the Hellenic Cancer Federation (ELLOK) and its President, George Kapetanakis, for the kind invitation and the opportunity to contribute to this important dialogue.